Benitec Biopharma Cash Flow Statement (2019-2025) | BNTC

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-3.79M-3.86M-4.82M-4.85M-3.47M-4.75M-4.59M-5.62M-4.35M-4.56M-5.88M-6.93M-4.14M-4.63M-5.19M-1.37M-4.32M-8.80M-8.79M-11.99M
Depreciation and Depletion (Quarter)
0.07M0.05M0.05M0.06M0.05M0.01M0.04M0.02M
Share-based Compensation (Quarter)
0.23M0.28M0.27M0.24M0.19M0.17M0.30M-0.05M0.07M0.13M0.09M0.09M0.19M0.45M0.43M3.14M5.96M10.08M5.18M7.38M
Gains from Investment Securities (Quarter)
0.79M4.90M1.96M
Non-cash Items (Quarter)
7.73M14.82M
Cash from Operations (Quarter)
-1.99M-5.12M-4.30M-3.32M-3.42M-4.86M-4.04M-5.86M-4.02M-4.09M-4.60M-5.30M-6.20M-3.30M-4.59M-7.70M-3.09M-8.21M-3.35M-3.75M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.05M0.05M0.05M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.07M0.07M0.07M-0.07M0.33M0.10M0.11M
Amortization of Deferred Charges (Quarter)
0.05M0.05M0.05M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.07M0.07M0.07M0.07M0.09M0.10M0.10M0.11M
Depreciation & Amortization (CF) (Quarter)
0.07M0.05M0.05M0.06M0.05M0.01M0.04M0.04M0.03M0.02M0.02M0.02M0.03M0.03M0.03M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Receivables (Quarter)
0.01M-0.01M-0.05M0.05M0.18M-0.23M0.23M-0.20M-0.03M-0.12M
Change in Account Payables (Quarter)
1.64M-1.16M0.29M0.85M-0.63M0.58M0.50M-0.55M0.63M0.78M0.57M1.14M-2.31M1.54M-0.32M1.30M-3.84M0.48M0.12M0.70M
Change in Accured Expenses (Quarter)
0.03M0.07M-0.01M0.00M0.03M0.05M-0.01M0.01M0.04M0.04M-0.00M0.05M0.00M-0.01M0.02M-0.09M0.16M-0.16M0.04M0.02M
Investing Activities
Capital Expenditures (Quarter)
0.01M-0.14M0.01M0.00M0.01M
Sales of Property, Plant and Equipment (Quarter)
Cash from Investing Activities (Quarter)
-0.01M0.14M-0.01M-0.18M-0.01M-0.01M-0.01M
Financing Activities
Other financing activities (Quarter)
1.58M1.87M2.96M2.93M0.00M2.25M0.07M
Change in Capital Stock
Shares Issued (Quarter)
0.00M14.25M17.88M30.88M0.04M-0.04M40.00M30.46M0.00M
Misc.
Cash from Financing Activities (Quarter)
0.00M12.67M16.02M27.92M0.04M40.07M21.66M17.87M28.41M2.54M98.23M
Exchange Rate Effect (Quarter)
-0.02M0.13M0.24M-0.05M-0.28M0.30M0.50M-0.15M0.04M0.02M0.04M-0.16M0.12M-0.01M-0.10M0.28M-0.02M-0.12M0.09M-0.13M
Change in Cash (Quarter)
-2.02M7.78M-4.04M-3.40M-3.70M-4.57M12.47M-6.00M-3.99M-4.08M23.39M-5.49M-6.23M36.77M16.98M-16.98M46.93M-3.27M94.31M
Free Cash Flow (Quarter)
-2.00M-4.98M-4.30M-3.32M-3.42M-4.87M-4.04M-5.86M-4.02M-4.10M-4.60M-5.30M-6.20M-3.30M-4.59M-7.70M-3.09M-8.21M-3.35M-3.75M
Net Cash Flow (Quarter)
-2.00M7.68M-4.30M-3.32M-3.42M-4.87M11.97M-5.86M-4.02M-4.09M23.32M-5.26M-6.38M36.77M17.07M10.15M25.32M-5.67M-3.35M94.47M